NEXT

National Law Journal

Regulators' Inquiries Into Aetna Claims Review Practices Not Likely to Derail CVS Merger: Lawyers

Insurance commissioners in California and Colorado recently announced plans to scrutinize Aetna's practices for granting and denying health care claims—developments that in and of themselves are unlikely to be deal breakers in the insurance giant's proposed $69 billion merger with CVS Health, corporate lawyers say.
5 minute read

New York Law Journal

Litigation Won't Cure America's Opioid Epidemic

States and municipalities have brought over 200 lawsuits against opioid distributors and manufacturers in the United States, in response to the Opioid Epidemic. Using civil suits to solve this public health problem is not a proper function of the justice system. Opportunistic litigation diverts attention from the need for properly targeted public policy solutions.
9 minute read

Texas Lawyer

DLA Piper Expands in Dallas Again — This Time with Dentons Hires

C. Michael Moore specializes in pharmaceutical work and also handles unfair trade practices, state attorney general matters, governmental fraud. Matthew Nickel focuses on product liability and pharmaceutical litigation.
3 minute read

The Recorder

Recent Decisions Provide Ammo for Challenging Expert Testimony Supporting Class Cert

Class action plaintiffs often submit expert testimony in support of class certification motions, raising the question of how defendants should respond—particularly when the plaintiff's evidence is unreliable or otherwise deficient.
8 minute read

Litigation Daily

Kirkland's Hurst Wins, and Then He Wins Some More—How Does He Do It?

"In order to do a good job at trial, you can't just parachute in and know half the facts. You have to know everything," says Kirkland & Ellis star litigator James Hurst. "The reality is, that takes time—late nights, early mornings, lots of weekends. But it's the only way to make it work."
9 minute read

New Jersey Law Journal

Shareholder Suit Targets Johnson & Johnson Disclosures on Asbestos in Talc

The company artificially inflated its stock price by failing to disclose what it knew about links between cancer and Johnson's Baby Powder, according to the suit.
4 minute read

New York Law Journal

Latest Efforts to Curb Opioid Epidemic in NY: Controlled Substance Schedule Changes

Under a 30-day budget amendment that Gov. Andrew Cuomo recently announced, 11 fentanyl analogs will be added to the state controlled substances schedule and the New York health commissioner will have the authority to add to the state controlled substances list new drugs that are added to the federal schedule.
3 minute read

Connecticut Law Tribune

3 Conn. Cities Release Fee Agreements in Opioid Lawsuits

The fee agreements between the state's largest communities and the law firms representing them in their lawsuit against Big Pharma related to the opioid epidemic call on those communities to pay nothing unless they prevail.
4 minute read

Daily Report Online

South Georgia County, Hospital Authority Sue Over Opioid Addiction

Attorneys at an Athens firm with a growing national reputation as leaders in medical MDL are representing Candler County and the county hospital authority in their fight against drug manufacturers and distributors.
4 minute read

The Recorder

Lying Witness or Not, Merck Might Salvage $200M Verdict in Hep C Battle

In an appellate showdown between Fish & Richardson's Juanita Brooks and MoloLamken's Jeffrey Lamken, a Federal Circuit panel seemed swayed by Merck's argument that one bad witness didn't taint the jury's verdict.
6 minute read

Resources

  • Aligning Client Needs with Lawyer Growth and Profitability

    Brought to you by BigHand

    Download Now

  • Technology to Make E-Discovery Smarter, Not Harder

    Brought to you by Nuix

    Download Now

  • Does Generative AI Have the Power to Transform Legal Services?

    Brought to you by HaystackID

    Download Now

  • International Export and Trade Assistance State Law Survey

    Brought to you by LexisNexis®

    Download Now